Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



Google+

At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.




Latest Member Blogs

Member
Total Posts: 1
6/14/2017
09:29PM
Member
Total Posts: 1
6/14/2017
02:18PM
Member
Total Posts: 1
6/13/2017
09:49AM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
Clal Biotechnology Industries Ltd. (TASE:CBI) Company Valuation & Investor Review - JCTY News

Clal Biotechnology Industries Ltd. (TASE:CBI) Company Valuation & Investor Review
JCTY News
Clal Biotechnology Industries Ltd. (TASE:CBI) has a Q.i. Value of 87.00000. The purpose of the Q.i. Value is to help identify companies that are the most undervalued. Typically, the lower the value, the more undervalued the company tends to be. The Q.i ...

and more »
Boston Advisors LLC Sells 1155 Shares of Veracyte, Inc. (NASDAQ:VCYT) - Chaffey Breeze

Boston Advisors LLC Sells 1155 Shares of Veracyte, Inc. (NASDAQ:VCYT)
Chaffey Breeze
Veracyte logo Boston Advisors LLC reduced its position in Veracyte, Inc. (NASDAQ:VCYT) by 2.4% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 47,290 shares of the biotechnology company's ...

and more »
Insider Buying: Opko Health, Inc. (OPK) CEO Buys 36200 Shares of Stock - BNB Daily (blog)

BNB Daily (blog)

Insider Buying: Opko Health, Inc. (OPK) CEO Buys 36200 Shares of Stock
BNB Daily (blog)
Public Employees Retirement Association of Colorado now owns 73,417 shares of the biotechnology company's stock valued at $483,000 after buying an additional 216 shares in the last quarter. Pinnacle Associates Ltd. boosted its stake in Opko Health by ...

Brain Biotechnology RCH & Info Netwk AG (BNN.DE) Touches Lower Band; Is a Reversal in Store? - Geneva Journal

Brain Biotechnology RCH & Info Netwk AG (BNN.DE) Touches Lower Band; Is a Reversal in Store?
Geneva Journal
Brain Biotechnology RCH & Info Netwk AG (BNN.DE) share levels are being closely watched as the equity has touched it's lower Bollinger Band, reaching 18.40 on a recent tick. The Bollinger Band theory is designed to depict the volatility of a stock. It ...

and more »
BTIG Research Reaffirms Buy Rating for Galapagos NV (GLPG) - TheOlympiaReport

BTIG Research Reaffirms Buy Rating for Galapagos NV (GLPG)
TheOlympiaReport
Galapagos NV logo Galapagos NV (NASDAQ:GLPG)'s stock had its “buy” rating reissued by investment analysts at BTIG Research in a note issued to investors on Wednesday, July 26th. They currently have a $98.00 target price on the biotechnology ...

and more »
Cellect Biotechnology Ltd. (TASE:APOP) Update on QI & Valuation - DARC News

Cellect Biotechnology Ltd. (TASE:APOP) Update on QI & Valuation
DARC News
Cellect Biotechnology Ltd. (TASE:APOP) currently has a Q.i. Value of 50.00000. Investors often have a large selection of stocks to research when looking to add to the portfolio. Investors have the ability to employ many different strategies to help ...

and more »
Aeglea BioTherapeutics Inc. - Receive News & Ratings Daily - Rincon Hill News

Aeglea BioTherapeutics Inc. - Receive News & Ratings Daily
Rincon Hill News
Zacks Investment Research upgraded shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE) from a hold rating to a buy rating in a report issued on Thursday, August 3rd. The brokerage currently has $3.75 target price on the biotechnology company's stock.

and more »
Igene Biotechnology Inc (IGNE) Sees Schaff Trend Cycle Trend Upward Near-Term - Buckeye Business Review

Igene Biotechnology Inc (IGNE) Sees Schaff Trend Cycle Trend Upward Near-Term
Buckeye Business Review
Igene Biotechnology Inc (IGNE) are being monitored this week as the Schaff Trend Cycle levels have shown a consistent uptrend over the course of the past 5 trading sessions. If the levels breach the key 70 level, a market reversal will be likely ...

and more »
Emerald Advisers Inc. PA Has $20.61 Million Stake in bluebird bio, Inc. (BLUE) - The Cerbat Gem

Emerald Advisers Inc. PA Has $20.61 Million Stake in bluebird bio, Inc. (BLUE)
The Cerbat Gem
bluebird bio logo Emerald Advisers Inc. PA raised its stake in bluebird bio, Inc. (NASDAQ:BLUE) by 207.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 196,174 shares of the biotechnology company's ...

and more »
vTv Therapeutics Inc. (NASDAQ:VTVT) PT Set at $13.00 by HC Wainwright - BNB Daily (blog)

vTv Therapeutics Inc. (NASDAQ:VTVT) PT Set at $13.00 by HC Wainwright
BNB Daily (blog)
The firm currently has a buy rating on the biotechnology company's stock. Separately, Zacks Investment Research lowered vTv Therapeutics from a buy rating to a hold rating in a report on Tuesday, May 30th. Five equities research analysts have rated the ...

and more »